Navigation Links
Boston Scientific Announces Results For First Quarter Ended March 31, 2009
Date:4/20/2009

sessing performance. Accordingly, management excluded these charges for purposes of calculating these non-GAAP measures to facilitate an evaluation of the Company's current operating performance and a comparison to the Company's past operating performance.

  • Litigation-related charges -These charges are attributable to certain patent litigation matters. These amounts represent significant charges during the first quarter of 2009 and do not reflect expected on-going operating expenses. Accordingly, management excluded these charges for purposes of calculating these non-GAAP measures to facilitate an evaluation of the Company's current operating performance and for comparison to the Company's past operating performance.

  • Discrete tax items - These items represent current period adjustments of certain tax positions, which were initially recorded in prior periods associated with the Company's acquisition-, divestiture-, litigation- and restructuring related charges. These adjustments do not reflect expected on-going operating results. Accordingly, management excluded these amounts for purposes of calculating these non-GAAP measures to facilitate an evaluation of the Company's current operating performance and for comparison to the Company's past operating performance.

  • Amortization expense - Amortization expense is a non-cash charge and does not impact the Company's liquidity or compliance with the covenants included in its debt agreements. Management removes the impact of amortization from the Company's operating performance to assist in assessing the Company's cash generated from operations. Management believes this is a critical metric for the Company in measuring the Company's ability to generate cash and pay down debt. Therefore, amortization exp
    '/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces New Initiatives to Increase Shareholder Value
7. Boston Scientific Announces Additions to Clinical Sciences Organization
8. Boston University School of Medicine physician receives award from AATOD
9. Boston Scientific Announces Verdict in Cordis Litigation
10. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... 29, 2015 The culmination of one of ... when the Final Four invades Lucas Oil Stadium ... been one filled with excitement, buzzer-beaters, and of course, upsets. ... superstars have been made, and future professional products have been ... to the four teams that advanced through their regional bracket ...
(Date:3/29/2015)... Youth Villages will participate in a partnership ... the feasibility of implementing a Pay for Success model ... their families. , Third Sector Capital Partners Inc. ran ... provided technical assistance throughout 2015 toward a Pay for ... awardees chosen by Third Sector. The organization’s work with ...
(Date:3/28/2015)... Coffee could not only perk you up in the ... researchers have found. , They found that those who drank ... Antioxidants fight gum disease. Does coffee, then, help fight gum ... M. Goldman School of Dental Medicine explored in a ... Journal of Periodontology. , “This is the first long-term study ...
(Date:3/28/2015)... New York, New York (PRWEB) March 28, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. ... multidistrict litigation underway in U.S. District Court, Southern ... Jeffrey S. Grand, is serving on the Plaintiffs’ ... March 24th, the Court has granted certain defendants ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site and ... Las Vegas warehouse, located at 4606 Andrews St. Suite 3, ... equipment from hospitals and surgery centers from around the United ... Buyers will find items of all types including anesthesia, endoscopy, ... Erik Tivin, CEO of Centurion. , Among the sale’s ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Medical Equipment Auction to Take Place in North Las Vegas 2
... Bethesda, MD (March 1, 2009) Even in the ... need colorectal cancer screening receive the life-saving test. Those ... not include colorectal cancer screenings are even less likely ... the American Gastroenterological Association (AGA) is working to raise ...
... eDiets.com meal delivery offering to over 30,000 MembersNew ... Third Partnership within the new Fitness Industry Sales ... DIET ), and Diversified Health & ... work together to promote eDiets, award-winning, fresh-prepared diet ...
... for Net Operating Income and Year-End Cash- Achieves 2008 ... Conference Call Webcast Wednesday, February 25, 8:30 a.m. EST ... 25 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... highlights. Isis exceeded its 2008 financial guidance by ...
... Value under the Current Board and Management TeamDiscloses Details ... StockholdersCINCINNATI, Feb. 25 The ... filed presentations with the Securities and Exchange Commission in ... to replace the existing Board of Directors of LCA-Vision, ...
... SOUTH SAN FRANCISCO, Calif., Feb. 25 Proteolix, Inc., ... therapeutics that target protein degradation pathways in cancer and ... Scarlett, M.D., to the position of President and Chief ... of experience in drug development and commercialization to his ...
... 25 With the economy taking a nose dive,Americans ... travel to even medical,treatments. Both healthcare and dental care ... to a recent survey by Cigna, a leading provider ... care of their health,because of the economy. In ...
Cached Medicine News:Health News:Economy could reduce colorectal cancer screening rate 2Health News:eDiets.com(R) and Diversified Health & Fitness Announce New Strategic Marketing Partnership 2Health News:eDiets.com(R) and Diversified Health & Fitness Announce New Strategic Marketing Partnership 3Health News:eDiets.com(R) and Diversified Health & Fitness Announce New Strategic Marketing Partnership 4Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 2Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 3Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 4Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 5Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 6Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 7Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 8Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 9Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 10Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 11Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 12Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 13Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 14Health News:Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008 15Health News:The LCA-Vision Full Value Committee Files Detailed Presentations 2Health News:The LCA-Vision Full Value Committee Files Detailed Presentations 3Health News:Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO 2Health News:Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO 3Health News:Put Your Money Where Your Mouth Is - Brush Up on Your Oral Health Today for a Healthier Tomorrow 2
(Date:3/27/2015)... --  Hospira, Inc. (NYSE: HSP ), ... leading provider of injectable drugs and infusion technologies, ... biosimilarity of its proposed biosimilar, Epoetin Hospira, with ... approved name of RETACRIT™, compared to the reference ... were presented at the National Kidney Foundation (NKF) ...
(Date:3/27/2015)... , March 27, 2015 ... 2015" therapeutic market research report of 52 pages ... online business intelligence library. The report ... on the therapeutic development for Visceral Pain, complete ... by drug target, mechanism of action (MoA), route ...
(Date:3/27/2015)... 2015  WebMD Health Corp. (NASDAQ: ... information, today announced an exclusive White House ... Plan for Combating Antibiotic-Resistant Bacteria . During ... and importance of addressing antibiotic-resistant bacteria and ... The WebMD interview, available online ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3
... Schering-Plough,Corporation (NYSE: SGP ) and The ... of Baltimore today announced results of the ... Eptifibatide to,Arrest the Reactivity of Platelets) study, ... IIIa inhibitor, significantly inhibited,platelet aggregation when added ...
... Immtech Pharmaceuticals,Inc. (Amex: IMM ) today ... a,scientific consortium led by the University of North ... The Bill & Melinda Gates Foundation,(the "Gates Foundation"), ... and leishmania. This grant is part of the ...
Cached Medicine Technology:Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 2Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 3Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 4Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting 5Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 2Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials 3
... The Venus-i™ Laser System is a new, ... system with applications in dermatology, cosmetic and ... An ideal laser for skin resurfacing, it ... powerful, Erbium:YAG lasers on the market. It ...
... biolitecs sophisticated Ceralas D15/810 diode laser is ... ideal for many soft tissue applications. With ... D15/810 features a flexible fiber optic delivery ... irrigated or dry environments alike.,Compact and portable, ...
... D 980 nm diode laser provides controlled ... for most surgical procedures. Unlike other ... without collateral tissue damage or charring. ... instantly and seals small blood vessels ...
... The TonoPach is a device intended for ... IOP remains the single most important metric ... However, as discovered in a large, ... study published in mid-2002, the patients central ...
Medicine Products: